Marilena Vrana: The Final Day of IPPC 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“The final day of IPPC 2026 was incredibly impactful.
The day got off to a fast start with David Osgathorp, a leading expert on professional performance and resilience from Red Bull Racing and Red Bull Technology.
His lessons learned from working with professional athletes set the tone for a dynamic and engaging panel on the next generation of leadership in the unique plasma sector.
I will be reflecting on some of these profound insights as my own career continues in this space.
The panel set the direction for how PPTA Europe can further engage and support the next generation.
Today’s final panels pushed us to think bigger about donor health and safety, as well as what it would really take to boost plasma collection in Europe.
International Plasma Protein Congress is an opportunity for ideas to turn into action, and this year truly delivered.
Already looking ahead to IPPC2027 in Barcelona, now less than a year away.
Let’s keep the momentum going!
See you on 20-21 April 2027.

More posts featuring Marilena Vrana on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering